Central Role of Gimap5 in Maintaining Peripheral Tolerance and T Cell Homeostasis in the Gut

Inflammatory bowel disease (IBD) including Crohn’s disease and ulcerative colitis is often precipitated by an abnormal immune response to microbiota due to host genetic aberrancies. Recent studies highlight the importance of the host genome and microflora interactions in the pathogenesis of mucosal...

Full description

Saved in:
Bibliographic Details
Main Authors: Mehari Endale, H. Ibrahim Aksoylar, Kasper Hoebe
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2015/436017
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552125148692480
author Mehari Endale
H. Ibrahim Aksoylar
Kasper Hoebe
author_facet Mehari Endale
H. Ibrahim Aksoylar
Kasper Hoebe
author_sort Mehari Endale
collection DOAJ
description Inflammatory bowel disease (IBD) including Crohn’s disease and ulcerative colitis is often precipitated by an abnormal immune response to microbiota due to host genetic aberrancies. Recent studies highlight the importance of the host genome and microflora interactions in the pathogenesis of mucosal inflammation including IBD. Specifically, genome-wide (GWAS) and also next-generation sequencing (NGS)—including whole exome or genome sequencing—have uncovered a large number of susceptibility loci that predispose to autoimmune diseases and/or the two phenotypes of IBD. In addition, the generation of “IBD-prone” animal models using both reverse and forward genetic approaches has not only helped confirm the identification of susceptibility loci but also shed critical insight into the underlying molecular and cellular pathways that drive colitis development. In this review, we summarize recent findings derived from studies involving a novel early-onset model of colitis as it develops in GTPase of immunity-associated protein 5- (Gimap5-) deficient mice. In humans, GIMAP5 has been associated with autoimmune diseases although its function is poorly defined. Here, we discuss how defects in Gimap5 function impair immunological tolerance and lymphocyte survival and ultimately drive the development of CD4+ T cell-mediated early-onset colitis.
format Article
id doaj-art-dbe40fc05eda4e3ca3f7942771226a88
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-dbe40fc05eda4e3ca3f7942771226a882025-02-03T05:59:31ZengWileyMediators of Inflammation0962-93511466-18612015-01-01201510.1155/2015/436017436017Central Role of Gimap5 in Maintaining Peripheral Tolerance and T Cell Homeostasis in the GutMehari Endale0H. Ibrahim Aksoylar1Kasper Hoebe2Department of Molecular and Cellular Immunology, Cincinnati Children’s Hospital Research Foundation, MLC7021, Room S5.421, 3333 Burnet Avenue, Cincinnati, OH 45229-3039, USADepartment of Genetics and Complex Diseases, Harvard School of Public Health, Boston, MA 02115, USADepartment of Molecular and Cellular Immunology, Cincinnati Children’s Hospital Research Foundation, MLC7021, Room S5.421, 3333 Burnet Avenue, Cincinnati, OH 45229-3039, USAInflammatory bowel disease (IBD) including Crohn’s disease and ulcerative colitis is often precipitated by an abnormal immune response to microbiota due to host genetic aberrancies. Recent studies highlight the importance of the host genome and microflora interactions in the pathogenesis of mucosal inflammation including IBD. Specifically, genome-wide (GWAS) and also next-generation sequencing (NGS)—including whole exome or genome sequencing—have uncovered a large number of susceptibility loci that predispose to autoimmune diseases and/or the two phenotypes of IBD. In addition, the generation of “IBD-prone” animal models using both reverse and forward genetic approaches has not only helped confirm the identification of susceptibility loci but also shed critical insight into the underlying molecular and cellular pathways that drive colitis development. In this review, we summarize recent findings derived from studies involving a novel early-onset model of colitis as it develops in GTPase of immunity-associated protein 5- (Gimap5-) deficient mice. In humans, GIMAP5 has been associated with autoimmune diseases although its function is poorly defined. Here, we discuss how defects in Gimap5 function impair immunological tolerance and lymphocyte survival and ultimately drive the development of CD4+ T cell-mediated early-onset colitis.http://dx.doi.org/10.1155/2015/436017
spellingShingle Mehari Endale
H. Ibrahim Aksoylar
Kasper Hoebe
Central Role of Gimap5 in Maintaining Peripheral Tolerance and T Cell Homeostasis in the Gut
Mediators of Inflammation
title Central Role of Gimap5 in Maintaining Peripheral Tolerance and T Cell Homeostasis in the Gut
title_full Central Role of Gimap5 in Maintaining Peripheral Tolerance and T Cell Homeostasis in the Gut
title_fullStr Central Role of Gimap5 in Maintaining Peripheral Tolerance and T Cell Homeostasis in the Gut
title_full_unstemmed Central Role of Gimap5 in Maintaining Peripheral Tolerance and T Cell Homeostasis in the Gut
title_short Central Role of Gimap5 in Maintaining Peripheral Tolerance and T Cell Homeostasis in the Gut
title_sort central role of gimap5 in maintaining peripheral tolerance and t cell homeostasis in the gut
url http://dx.doi.org/10.1155/2015/436017
work_keys_str_mv AT mehariendale centralroleofgimap5inmaintainingperipheraltoleranceandtcellhomeostasisinthegut
AT hibrahimaksoylar centralroleofgimap5inmaintainingperipheraltoleranceandtcellhomeostasisinthegut
AT kasperhoebe centralroleofgimap5inmaintainingperipheraltoleranceandtcellhomeostasisinthegut